Inventor
William Frietze
Inventor
Kennett Square, PA, US
Overview
Patents· 17 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
A61KPreparations for medical, dental or toiletry purposes19%
C07CAcyclic or carbocyclic compounds15%
Y02PClimate change mitigation technologies in the production or processing of goods6%
C07BGeneral methods of organic chemistry2%
PatentTitleYear
11,066,394Solid forms of an HPK1 inhibitor202110,858,372Amorphous solid form of a BET protein inhibitor202010,329,305Amorphous solid form of a BET protein inhibitor201910,280,157Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor20199,873,688Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor20189,321,755'Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor'20169,035,065'Ethanamine compounds and methods of using the same'20158,013,165'Ethanamine compounds and methods of using the same 545'20116,589,958'Isoxazolo 4,5-d pyrimidines as CRF antagonists'20036,579,876'Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists'20036,521,636'Imidazo-pyridines as corticotropin releasing factor antagonists'20036,509,338'Pyrazolo1,5-Atriazine corticotropin releasing factor antagonists'20036,365,589'Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists'20026,348,504'Oxime ethers as IIb/IIa antagonists'20026,294,671'Isoxazolo[4, 5-D]pyrimidines as CRF antagonists'20016,218,391'Triazinones and derivatives thereof'20016,159,980'Pyrazinones and triazinones and their derivatives thereof'2000Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2000–2001Patents assigned to DU PONT PHARM CO (3)· patent assignee history
2000–2020Based in Kennett Square, PA, US· patent location history
2002–2003Patents assigned to BRISTOL MYERS SQUIBB PHARMA CO (3)· patent assignee history
2011–2015Patents assigned to ASTRAZENECA AB (2)· patent assignee history
2011–2015Based in Wilmington, DE, US· patent location history
2016–2021Patents assigned to INCYTE CORP (6)· patent assignee history
2016–2019Patents assigned to INCYTE HOLDINGS CORP (3)· patent assignee history
2021Based in Kenneth Square, PA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INCYTE CORP | 6 | 2016–2021 |
| BRISTOL MYERS SQUIBB PHARMA CO | 3 | 2002–2003 |
| DU PONT PHARM CO | 3 | 2000–2001 |
| INCYTE HOLDINGS CORP | 3 | 2016–2019 |
| ASTRAZENECA AB | 2 | 2011–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Kennett Square, Pennsylvania, US | 14 | 2000–2020 |
| Wilmington, Delaware, US | 2 | 2011–2015 |
| Kenneth Square, Pennsylvania, US | 1 | 2021 |